EIPA-L593754-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁(yè)
EIPA-L593754-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁(yè)
EIPA-L593754-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEEIPACat. No.: HY-101840CAS No.: 1154-25-2Synonyms: L593754; MH 12-43; Ethylisopropylamiloride分式: CHClNO分量: 299.76作靶點(diǎn): TRP Channel; Sodium Channel作通路: Membrane Transporter/Ion Channel; Neuronal Signaling儲(chǔ)存式: Powder -20C 3 yearsIn

2、 solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 140 mg/mL (467.04 mM; Need ultrasonic)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 3.3360 mL 16.6800 mL 33.3600 mL5 mM 0.6672 mL 3.3360 mL 6.6720 mL10 mM 0.3336 mL 1.6680 mL 3.3360 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。體內(nèi)實(shí)驗(yàn) 請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給

3、藥式選擇適當(dāng)?shù)娜芙獍福渲魄罢?qǐng)先配制澄清的儲(chǔ)備液,再依次添加助溶劑(為保證實(shí)驗(yàn)結(jié)果的可靠性,體內(nèi)實(shí)驗(yàn)的作液,建議您現(xiàn)現(xiàn)配,當(dāng)天使;澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;以下溶劑前的百分 指該溶劑在您配制終溶液中的體積占):1. 請(qǐng)依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.33 mg/mL (7.77 mM); Clear solution2. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.33 mg/mL (7.77 mM); C

4、lear solution1/2 Master of Small Molecules 您邊的抑制劑師www.MedChemEBIOLOGICAL ACTIVITY物活性 EIPA種 TRPP3 channel 抑制劑,其 IC50 值為 10.5 M。EIPA 還抑制 Na+/H+ 交換 (NHE) 和巨噬細(xì)胞。IC50 & Target IC50: 10.5 M (TRPP3 channel) 1NHE 2Macropinocytosis 3體外研究 In the presence of 500 M amiloride, 100 M EIPA, 10 M benzamil, and 10 M

5、 phenamil, 45Ca2+ uptakedecreases from 799 to 464 (58% remaining), 274 (34%), 295 (37%), and 384 (48%) pmol/oocyte/30min (n=6, P=0.008), respectively. It is found that EIPA, benzamil, and phenamil rapidly and reversibly blockCa2+-activated TRPP3 channel activation at -50 mV, with IC50s of 1438 (n=36

6、), 10.52.2 (n=28), 1.10.3(n=30), and 0.140.04 M (n=25), respectively 1. The number of autophagic vacuoles increasesdramatically in the HAE and HPE groups after EIPA treatment compare with the HAN and HPN groups. EIPAregulates the initiation and maturation of the autophagy associated with amino acids

7、 in IEC-18 cells 2. Inaddition, the uptake of cinnamoylphenazine (CA-PZ) and neutral red (NR) is inhibited by EIPA 3.PROTOCOLCell Assay 2 The effect of EIPA alone (without alanine or proline) is also examined in both control (DMEM cultured cells)and amino acid-starved cells. The cells are incubated

8、for 6 h in DMEM containing 5% FBS and either 0 or 0.3mM EIPA (labelled QNN and QNE, respectively), HBSS containing either 0 or 0.3 mM EIPA (labelled HNNand HNE, respectively), HBSS with 1.0 mM alanine (labelled HAN) or 0.5 mM proline (labelled HPN), HBSSwith 1.0 mM alanine and 0.3 mM EIPA (labelled

9、HAE), and HBSS with 0.5 mM proline and 0.3 mM EIPA(labelled HPE) 2.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Dai XQ, et al. Inhibition of TRPP3 channel by amiloride and analogs. Mol Pharmacol. 2007 Dec;72(6):1576-85.2. Shi H, et al. N

10、a+/H+ Exchanger Regulates Amino Acid-Mediated Autophagy in Intestinal Epithelial Cells. Cell Physiol Biochem.2017;42(6):2418-2429.3. Zhu BY, et al. A new HDAC inhibitor cinnamoylphenazine shows antitumor activity in association with intensive macropinocytosis.McePdfHeightCaution: Product has not been fully valida

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論